3510774-m01annc

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.



Bloomage BioTechnology Corporation Limited

華 熙 生 物 科 技 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 00963)


POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 17 DECEMBER 2015


The Board is pleased to announce that all the resolutions as set out in the EGM Notice were duly passed at the EGM held on 17 December 2015.


Reference is made to the notice of the extraordinary general meeting (the "EGM") dated 2 December 2015 (the "EGM Notice") of Bloomage BioTechnology Corporation Limited (the "Company"). Unless otherwise defined, capitalized terms used herein shall have the same meanings as defined in the circular of the Company dated 2 December 2015.


The Board announces that at the EGM held at 23/F, Block D, Central International Trade Centre, No. 6A, Jianguomenwai Avenue, Chaoyang District, Beijing, the People's Republic of China on 17 December 2015 at 10:30 a.m., poll voting was adopted for all the resolutions as set out in the EGM Notice (the "Resolutions").

The Board is pleased to announce that all the Resolutions were duly passed by the Shareholders by poll voting at the EGM. The poll results for the Resolutions are as follows.



Ordinary Resolutions

Number of Votes (%)


Total Votes

For

Against

1.

(a) To approve and confirm the management subscription agreements dated 6

November 2015 (the "Management Subscription Agreements") entered into between the Company and each of the Subscribers (as defined in the circular of the Company dated 2 December 2015 (the "Circular")) as set out in the Circular.

229,589,324

(90.26%)

24,784,794

(9.74%)

254,374,118

(100%)

(b) To approve the allotment and issue of the Management Subscription Shares (as defined in the Circular) to the Subscribers in accordance with the terms of the Management Subscription Agreements and the transactions contemplated thereunder.

222,879,324

(87.62%)

31,494,794

(12.38%)

254,374,118

(100%)

(c) To authorise any one director of the Company to do all such further acts and things and take all steps which may be in his/her opinion necessary, desirable or expedient to implement and/or give effect to the terms of the Management Subscription Agreements and the transactions contemplated thereunder.

222,879,324

(87.62%)

31,494,794

(12.38%)

254,374,118

(100%)


The description of the Resolutions above is by way of summary only. The full text appears in the EGM Notice.

As more than 50% of the votes were cast in favour of each of the Resolutions, the Resolutions were duly passed as ordinary resolutions of the Company.


The Hong Kong branch share registrar and transfer office of the Company, Tricor Investor Services Limited was appointed as the scrutineer for the poll voting at the EGM.


Notes:


  1. The total number of shares of the Company in issue as at the date of the EGM: 351,187,334 shares of HK$0.01 each. Each of Mr. Jin, Fu Qin, Li Zhi, Fan Yuan, Li Zhen, Li Chunfan and their respective associates (holding an aggregate of 752,500 Shares as at the date of the EGM) had abstained from voting at the EGM as a result of them having material interest in the Management Subscription Agreements and the transactions contemplated thereunder.


  2. The total number of shares of the Company entitling the holders to attend and vote only against the Resolutions at the EGM: nil.


  3. The total number of shares of the Company entitling the holders to attend and to vote for or against the Resolutions at the EGM: 350,434,834 shares.



Hong Kong, 17 December 2015

By Order of the Board

Bloomage BioTechnology Corporation Limited Zhao Yan

Chairman


As at the date of this announcement, the executive Directors are Ms. Zhao Yan, Mr. Jin Xuekun, Ms. Liu Aihua and Ms. Wang Aihua; the non-executive Director is Mr. Guo Jiajun; the independent non-executive Directors are Ms. Zhan Lili, Mr. Hai Wen and Mr. Li Junhong.

Bloomage BioTechnology Corporation Ltd. issued this content on 2015-12-17 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2015-12-17 11:14:35 UTC

Original Document: http://www.bloomagebio-tech.com/attachment/2015121718470100002389908_en.pdf